companyBiotechnologyUSA

Regeneron Pharmaceuticals

A biotechnology company specializing in the development of therapeutic antibodies and medicines.

Regeneron Pharmaceuticals is a biotechnology company headquartered in Tarrytown, New York. Founded by Leonard Schleifer and George Yancopoulos, the company has been listed on the NASDAQ under the ticker REGN since 1991 and employs approximately 15,000 people.

The company maintains a significant pipeline and engages in strategic partnerships with other pharmaceutical entities, including Sanofi, Bayer, and Alnylam. Recent corporate activities include acquisitions such as 23andMe and the monitoring of OPTIC test results.

Ideas that could help Regeneron Pharmaceuticals

FOP-Specific Quality of Life (QoL) Assessment Tool
A specialized clinical survey and tracking tool designed specifically to measure the unique health-related quality of life (HRQoL) challenges faced by patients with Fibrodysplasia Ossificans Progressiva.
Why it helps: Companies developing orphan drugs for FOP require validated HRQoL endpoints for clinical trials and regulatory approval.